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doi:10.1016/j.ejvs.2011.08.017Abstract Objectives: To compare outcomes after carotid endarterectomy (CEA) with saphe-
nous vein patch closure (SV), with cervical vein (external jugular and common facial) patch
closure (CV).
Design: A total of 322 cases of CEA was achieved consecutively by using venous patch angio-
plasty. Propensity scores were calculated followed by a one-to-one basis case-matching.
Materials: This resulted into 90 SV and 90 CV matched cases.
Methods: The primary endpoint was the incidence of ipsilateral stroke and transient ischaemic
attack at any time during follow-up.
Results: Ten-year freedom from stroke was 94.1%  3.5% for the SV group and 90.5%  4.2% for
the CV group (log rank P Z 0.230). Ten-year freedom from ipsilateral neurological events
(stroke and transient ischaemic attack) was 93.5%  3.3% for SV group and 92.4%  3.0% for
the CV group (log rank P Z 0.403). Ten-year freedom from 75% stenosis/occlusion was
93.1  4.8% for the SV group and 89.9  6.0% for the CV group (log rank P Z 0.481).
Conclusions: CV is a good alternative to SV patching, particularly when the SV needs to be
preserved for further use or is unsuitable.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Patch angioplasty has become an adjunct to carotid
endarterectomy (CEA) to reduce the incidence of peri-
operative thrombosis and the development of recurrent1423163.
uvain.be (Y. Louagie).
ty for Vascular Surgery. Publishecarotid stenosis.1e4 Autologous vein patches readily avail-
able include the saphenous vein (SV) and cervical vein (CV).
Advantages for the CV for carotid angioplasty include nod by Elsevier Ltd. All rights reserved.
Table 1 Demographic and clinical data: propensity score-
matched sample.
Saphenous
vein no.
(%)
Cervical
vein no.
(%)
P
No. of CEA procedures 90 90
Gender:
Male 69 (76.7) 65 (72.2) 0.617
Female 21 (23.3) 25 (27.8)
Mean age  SD (years) 67.7  8.6 67.6  9.5 0.987
Risk factors:
Smoking 46 (52.3) 42 (47.7) 0.665
Hypertension 57 (63.3) 56 (62.2) 1.000
Diabetes mellitus 21 (23.3) 17 (18.9) 0.571
Dyslipidaemia 35 (38.9) 37 (41.1) 0.860
Obesity 19 (21.1) 18 (20.0) 1.000
Peripheral vascular disease 28 (31.1) 30 (33.3) 0.871
Indications for CEA:
Hemispheric TIA 11 (12.2) 7 (7.8) 0.805
Amaurosis fugax 2 (2.2) 1 (1.1)
Hemispheric stroke 17 (18.9) 16 (17.8)
Nonhemispheric TIA 14 (15.6) 14 (15.6)
Asymptomatic 46 (51.1) 52 (57.8)
Side of symptoms:
Left hemisphere 19 (21.1) 11 (12.2)
Right hemisphere 7 (7.8) 10 (11.1) 0.529
Nonhemispheric 14 (15.6) 14 (15.6)
Unknown 4 (4.4) 3 (3.3)
Carotid lesions:
Stenosis 71 (78.9) 74 (82.2) 0.771
Ulcerated plaque 2 (2.1) 1 (1.1)
Ulcerated stenosis 17 (18.9) 15 (16.7)
Average degree of
stenosis (mean  SD %)
85  10 81  10 0.018
Side of procedure:
Right 36 (40.0) 39 (43.3) 0.728
Left 54 (60.0) 51 (56.7)
CEA, carotid endarterectomy; SD, standard deviation; TIA,
transient ischaemic attack.
Figure 1 Standardized differences for preoperative demo-
graphic variables comparing saphenous vein patch with cervical
vein patch groups in the original and the matched sample.
Outcome of Cervical Vein Carotid Patch Angioplasty 767cost for material, low risk for graft infection and preser-
vation of the SV. Compared with the abundant literature
involving SV patches, little has been reported on the use of
CV. Cervical veins evaluated for carotid patching include
the internal jugular vein,5e7 the external jugular vein8e11
and the common facial vein.8,10e12 The internal jugular
vein patch is opened longitudinally to form a panel from
which a patch could be fashioned, similar to the SV
patch.5,7 By contrast, based on experimental and clinical
studies by Dardik et al,8,13 the external jugular vein and the
common facial vein are used as double-layered everted
patches. We started using everted external jugular and
common facial veins for routine carotid patching as early as
January 1989. Our purpose in this study was to determine
whether there would be differences in perioperative
morbidity and long-term outcome between groups treated
with SV or CV patching.
Materials and Methods
Study design and patients’ selection
An analysis was conducted on a prospectively compiled
computerised database of all cases of CEA performed at our
institution from January 1989 to April 2009 under the care
of the same surgeon (YL). This study was approved by the
Institutional Ethics Committee of the University Clinics of
Mont Godinne under the national number B03920095355.
The Ethics Committee waived the need for patient consent.
A total of 322 cases of CEA was achieved consecutively in
276 patients by using venous patch angioplasty. The choice
of patch material was made by the surgeon with a priority
for the use of the CV to preserve the SV for further use.
Thus, 213 CV patches (153 external jugular and 60 common
facial) and 109 SV patches were used. Staged bilateral
procedures were realised in 46 patients during the study
period.
Using logistic regression, separate propensity scores
were calculated to estimate the probability (propensity) for
the use of an SV or CV patch. Nineteen relevant demo-
graphic covariates (mentioned in Table 1) were included to
complete the logistic regression. The cases were then
matched on a one-to-one basis using the SPSS propensity
matching program (John Painter, 2004, available from SPSS
Inc., Chicago, IL, USA) and following a greedy procedure
(the program finds the best match; the comparison case is
removed and not considered for subsequent matches). Two
matched groups of 90 patients undergoing an SV patch and
90 patients having a CV patch (64 external jugular and 26
common facial veins) were compared. The demographic
and clinical data resulting from matching are described in
Table 1. To assess the accuracy of matching, the standard
difference was used to compare the balance in preopera-
tive variables between the SV and the CV groups in the
matched sample with that in the unmatched sample.14 The
standardised difference was not influenced by sample size
and it has been suggested that a standardised difference of
>0.10 represents meaningful imbalance between treat-
ment groups. Fig. 1 reports standardised differences in
a graphical manner. The matching procedure markedly
improved the balance between the baseline variables.
768 Y. Louagie et al.Clinical evaluation
Pre- andpostoperative neurological eventswere classifiedby
the consultant neurologist as transient ischaemic attack
(temporary hemispheric symptoms lasting nomore than 24 h,
with complete recovery), amaurosis fugax (transient
monocular visual loss) or stroke (focal loss of cerebral func-
tion of vascular origin lasting more than 24 h). All patients
presenting a new neurological deficit after CEA underwent
brain computed tomography ormagnetic resonance imaging.
The diagnosis of an internal carotid artery lesion was
based on duplex ultrasound and confirmed by magnetic
resonance angiography or computed tomography angiog-
raphy. Digital subtraction angiography was performed
during the earlier part of our study. Before surgery, all
patients underwent a carotid colour duplex ultrasound
study that was completed by angiographic study in 167
(92.7%). There was no difference among the groups, except
for a higher stenosis degree in the SV group (Table 1).
Our patients were screened for coronary pathology by
myocardial scintigraphy. In addition, all candidates for
cardiac surgery underwent routine carotid echography
completed by angiography if a significant anomaly was
detected. Although randomised trials are still lacking, it is
our current policy to associate both surgeries when indi-
cated. We included in the study these patients having
concomitant carotid and cardiac surgery.
Based on the results of myocardial scintigraphy, coro-
nary arteriography was achieved in 50 patients. Significant
(>50%) left main stem disease was found in 18 patients (SV
group 9/26, CV group 9/24). Three-vessel disease,
excluding left main stem disease, was found in 24 patients
(SV group 13/26, CV group 11/24).
We considered, as emergency cases, patients operated
on within 6 h from the onset of acute neurological symp-
toms. Patients operated on within 48 h from the diagnosis
were considered urgent cases.
Operative technique
All CEA procedures were performed with the patient under
general anesthaesia with systemic heparin and routineTable 2 Operative data: propensity score-matched sample.
Saphenous vein n
Concomitant cardiac surgery:
None 63 (70.0)
CABG 24 (26.7)
AVR 3 (3.3)
Repeat CEA 2 (2.2)
Indwelling shunt 89 (98.9)
Ischaemic time (min: mean  SD) 14.9  5.8
Doppler data (mean  SD):
Flow rate (ml/min) 154.2  88.9
Velocity (cm/s) 21.4  9.3
Resistance (PRU) 0.74  0.52
Pulsatility index 1.66  1.42
CABG, isolated coronary artery bypass grafting; AVR, aortic valve rep
PRU, peripheral resistance units.shunting. This results in two periods of absence of perfu-
sion: before insertion and after removal of the shunt. The
ischaemic time reported in Table 2 represents the sum of
these two periods. Endarterectomies were extended prox-
imally and distally beyond grossly diseased intima. The
distal intima was usually tacked with three separate 6/
0 polypropylene sutures.
The greater SV was harvested at the level of the medial
malleolus and opened longitudinally. The patch was sutured
using 6/0 polypropylene. The technique of CV procurement
and suture was described in detail by Dardik et al.8 For
external jugular vein patch closure, the external jugular
vein was localised very superficially at the level of the
platissimus muscle. It was deemed as suitable if the diam-
eter exceeded 4 mm. A segment up to 6 cm long was har-
vested and everted by inserting a hook inside the lumen, so
that the intima became outermost (Fig. 2a and b). This
everted segment was sutured as a patch, taking into
account the orientation of the valves. Both walls needed to
be incorporated carefully into the suture at both ends
(Fig. 3a and b). In the absence of a suitable external jugular
vein, the common facial vein was dissected free and
separated from its tributaries. The branches were ligated
by fine silk ligatures or small clips. Usually, a shorter
segment could be obtained. This vein was everted in the
same manner and sutured. When concomitant cardiac
surgery was required, the CEA was performed first, the
wound left open, revisited for haemostasis and closed in
two layers at the end of the procedure.
Patency was assessed intraoperatively by using Doppler
ultrasound flowmeters (Scimed OPDOP 130, Bristol UK and
Cardiomed Trace System, Medi-Stim AS, Oslo, Norway).
Surveillance protocol
All patients underwent control Duplex cervical echography
and thorough otolaryngologic examinations including direct
laryngoscopy during the same hospitalisation. Follow-up by
the use of noninvasive methods was done 6 weeks later,
then by 6 months after operation, at the first year, and
annually thereafter. Patients with significant recurrent
stenosis or occlusion detected on duplex ultrasoundo. (%) Cervical vein no. (%) P
66 (73.3) 0.837
22 (24.4)
2 (2.2)
2 (2.2) 1.000
87 (96.7) 0.312
15.0  3.8 0.582
161.2  81.0 0.653
24.4  9.0 0.118
0.63  0.48 0.391
1.45  0.78 0.851
lacement; CEA, carotid endarterectomy; SD, standard deviation;
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angiography for confirmation of the diagnosis.
The primary endpoint was the relevant neurologic
complication rate at any time during follow-up. Secondary
endpoints included stroke-free survival, 30-day and long-
term mortality, recurrent stenosis rate, occlusion, patch
infection, aneurysm formation and other local
complications.
Statistical analysis
Values are presented as the mean  standard deviation
(SD). Numerical variables were compared between groups
by analysis of variance test and Wilcoxon signed-rank test
for matched pairs. Categorical variables were compared by
Pearson’s c2-test or McNemar’s test when indicated.
Survival and event-free curves were constructed by the
KaplaneMeier method and compared by the log-rank test.
These estimates included all patients from the day of
surgery, taking into account perioperative events. Cox
regression analysis using a forward stepwise (Wald) method
was used to test the variables influencing the endpoints
independently. The same variables used for the propensity
score computing were used as covariates for the creation of
the Cox models. In addition, the propensity score was used
as a covariate in the model. The nature of the patchFigure 2 These figures illustrate our method of everting an
external jugular vein. (a) A hook is introduced into the lumen
of the vein following the flow direction. (b) The opposite end of
the vein is grasped by the hook. The vein is everted by pulling
the tool.(saphenous, external jugular and common facial) was
included as a covariate. Statistical analyses were per-
formed using PASW Statistics 18 (SPSS Inc., Chicago, IL,
USA) and STATA 10 (StataCorp, College Station, TX, USA).Results
Perioperative characteristics and events
Intraoperative data
The operative data are described in Table 2. There was no
intraoperative thrombosis evidenced by pulsed Doppler
ultrasonography. There was no immediate stroke or tran-
sient ischaemic attack.
Hospital mortality
There were three hospital deaths (1.7%): one in the isolated
CEA group (1/129, 0.8%) and two (2/51, 3.9%) in the
concomitant cardiac surgery group (P Z 0.137). Perioper-
ative morbidity and mortality data are listed in Table 3.
There was no further death until the first postoperative
visit at 6 weeks.
Hospital morbidity
There were five cases of patients with a neck haemorrhage
requiring immediate surgery. The incidence was evenly
distributed among the groups. Three cases were related toFigure 3 (a) The everted external jugular vein patch is
sutured onto the internal carotid artery. A shunt was inserted.
(b) The patch suture is completed.
770 Y. Louagie et al.rupture of the running suture or stitch bleeding. In these
cases, thepatchwas intactandcouldbe resutured.Therewas
no need to replace the venous patch by another material.
In two further cases, parietal arterial bleeding caused
the cervical haematoma. One case was complicated by
coma and death (the only death after isolated CEA). There
was no patch disruption.
Early postoperative thrombosis of the internal carotid
artery was diagnosed by Duplex colour ultrasound in two
cases in the SV group, two cases in the external jugular
group and none in the common facial vein group (not
significant). Among these four cases of early thrombosis,
one was related to Takayasu arteritis, the patient being
treated by corticosteroids, and the other complicated
reoperation for haemorrhage (as described above).
Vocal cord palsy reached 8.3% incidence overall. Among
the 15 cases involved, 11 had logopaedic treatment and
four resolved spontaneously. There was no difference
between the groups.
There were three local infections requiring surgical
drainage. The first was a superinfected cervical haema-
toma. The two further infections were characterised by an
intense pyogenic reaction around BioGlue fragments
(Cryolife, Inc., Kennesaw, GA, USA) used as a fibrin
sealant.
There was no further complication until the first post-
operative visit at 6 weeks.
Follow-up results
Survival
The mean duration of follow-up for the 180 patients was
83.1  61.7 months (range 1e227). Duration of follow-upTable 3 Perioperative morbidity and mortality: propen-
sity score-matched sample.
Saphenous
vein no.
(%)
Cervical
vein no.
(%)
P
Ipsilateral neurological complications:
TIA 0 1 (1.1) 0.316
Stroke 1 (1.1) 1 (1.1) 1.000
Internal carotid thrombosis 2 (2.2) 2 (2.2) 1.000
Cranial nerve lesions:
Recurrent laryngeal 5 (5.6) 10 (11.1) 0.178
Hypoglossal 1 (1.1) 2 (2.2) 0.560
Mandibular facial branch 1 (1.1) 0 0.316
Reoperation for bleeding:
Patch suture 2 (2.2) 1 (1.1) 0.560
Cervical haematoma 0 2 (2.2) 0.155
Local infection 2 (2.2) 1 (1.1) 0.560
Duration of hospitalization (days, median, range):
Isolated CEA 6 (4e12) 7 (4e50) 0.337
Concomitant cardiac surgery 12 (9e21) 12 (8e55) 0.344
Hospital mortality:
Isolated CEA 1 (1.1) 0 0.316
Concomitant cardiac surgery 0 2 (2.2) 0.155
Overall 1 (1.1) 2 (2.2) 0.560
TIA, transient ischaemic attack; CEA, carotid endarterectomy.was 92.9  62.8 months in the SV group and 73.3  59.4
months in the CV group (P Z 0.033). Six patients were lost
to follow-up (3.3%). The patch used at the first procedure
identified the patch group of the patient in cases of
sequential bilateral procedure. KaplaneMeier survival
estimates are shown in Fig. 4. The 5- and 10-year survival
rates were 78.1%  4.9% and 65.8%  6.0% for the SV group,
and 67.5%  5.6% and 51.9%  6.5% for the CV group,
respectively (log rank P Z 0.063). Cox regression analysis
revealed the following variables that reduced survival
significantly: age at the procedure (P < 0.001) and diabetes
(PZ 0.007, odds ratioZ 2.13). The nature of the patch did
not influence survival independently. The causes of death
are detailed in Table 4. There was no difference between
the groups except for a greater incidence of sudden deaths
in the SV group.
Neurological events
Stroke-free KaplaneMeier estimates are shown in Fig. 5.
The 5- and 10-year rates of freedom from stroke rates were
98.9%  1.1% and 94.1%  3.5% for the SV group, and
93.2%  3.4% and 90.5%  4.2% for the CV group, respec-
tively (log rank PZ 0.230). Cox regression analysis revealed
only one variable associated with stroke: procedure priority
(P Z 0.013). The stroke incidence was 3.4% in elective
cases, 17.9% in urgent cases and 0% in emergency cases
(P Z 0.008). KaplaneMeier estimates of freedom from
ipsilateral neurological events (stroke and TIA) are shown in
Fig. 6. The 5- and 10-year event-free rates were
97.7%  1.6% and 93.5%  3.3% for the SV group, and
92.4%  3.0% and 92.4%  3.0% for the CV group, respec-
tively (log rank PZ 0.403). Cox regression analysis revealed
two variables associated with ipsilateral neurological
events: peripheral arteritis (PZ 0.004, odds ratio 9.84) and
left side of the procedure (P Z 0.047, odds ratio 8.16).
Long-term patency rate surveillance data
The postoperative status of the CEAs was evaluated during
hospital stay and at follow-up clinic examinations using
duplex ultrasound and/or angiography. The mean follow-up
time of the survey was 35.6  42.4 months (range 2
dayse205 months). This represents an average of 5.1Figure 4 KaplaneMeier curves showing overall survival;
P Z 0.063 for saphenous versus cervical vein patch. The esti-
mation starts on the day of the procedure.
Figure 6 KaplaneMeier curves showing freedom from ipsi-
lateral neurologic events (stroke, transient ischaemic attack);
P Z 0.403 for saphenous versus cervical vein patch. The esti-
mation starts on the day of the procedure.
Table 4 Causes of death: propensity score-matched
sample.
Saphenous
vein no.
(%)
Cervical
vein no.
(%)
P
Cardiac arrhythmia 2 (5.3) 1 (2.5) 0.526
Cardiac failure 2 (5.3) 6 (15.0) 0.157
Myocardial infarction 6 (15.8) 3 (7.5) 0.252
Sudden death 4 (10.5) 0 0.035
Stroke 2 (5.3) 1 (2.5) 0.526
Cerebral haemorrhage 0 1 (2.5) 0.327
Lung disease 5 (13.2) 3 (7.5) 0.410
Pulmonary embolism 1 (2.6) 1 (2.5) 0.971
Malignancy 7 (18.4) 5 (12.5) 0.469
GI disease 0 2 (5.0) 0.163
Renal failure 1 (2.6) 1 (2.5) 0.971
Sepsis 1 (2.6) 3 (7.5) 0.330
Diabetes 0 2 (5.0) 0.163
Perioperative/periprocedural 2 (5.3) 5 (12.5) 0.264
General deterioration 2 (5.3) 3 (7.5) 0.687
Miscellaneousa 2 (5.3) 3 (7.5) 0.687
Unknown 1 (2.6) 0 0.302
Total deaths 38 (100.0) 40 (100.0)
GI, gastrointestinal.
a Rupture of abdominal aortic aneurysm, suicide, digitalis
intoxication, Alzheimer’s disease, intravascular coagulopathy.
Outcome of Cervical Vein Carotid Patch Angioplasty 771examinations per patient (range 1e21). The 5- and 10-year
rates of freedom from 75% stenosis/occlusion were
97.7  1.6% and 93.1  4.8% for the SV group, and
89.9  6.0% and 89.9  6.0% for the CV group, respectively
(Fig. 7). There was no significant difference by log-rank
testing between the groups (P Z 0.481). Cox regression
analysis identified female gender as the only variable
independently influencing the advent of 75% stenosis/
occlusion (P Z 0.014, odds ratio Z 7.77).
One late thrombosis occurred 7 years after a left carotid
endarterectomy with SV patching associated with coronary
bypass surgery. There were two cases of severe stenosis,
both requiring reintervention.Figure 5 KaplaneMeier curves showing freedom from
stroke; PZ 0.230 for saphenous versus cervical vein patch. The
estimation starts on the day of the procedure.No aneurysm formation was observed during the follow-
up.
Data of patients excluded from the analysis
For the sake of completeness, demographic data and
results of the 96 patients excluded from the analysis were
summarised in Table 5.
Discussion
Among the numerous patch materials described, everted
CVs have several advantages. Those that are usually sacri-
ficed during exposure of the carotid arteries can be har-
vested by the same incision. The double-walled vein patch
has an increased tensile strength similar to the SV. The
greater SV can be preserved for future use and, thanks to
a better selection, the risk of a blowout described with the
use of a small diameter SV15 can be reduced. Everted
external and common facial veins can be used bilaterally
without impairing cerebral venous return, in contrast withFigure 7 KaplaneMeier curves showing freedom from
restenosis (75%) or occlusion; P Z 0.481 saphenous versus
cervical vein patch. The estimation starts on the day of the
procedure.
Table 5 Data of 96 patients excluded from the analysis.
No. (%)
Gender:
Male 69 (71.9)
Female 27 (28.1)
Mean age  SD (years) 72.1  8.6
Risk factors:
Smoking 48 (50.0)
Hypertension 59 (61.5)
Diabetes mellitus 27 (28.1)
Dyslipidaemia 39 (40.6)
Obesity 15 (15.6)
Peripheral vascular disease 41 (42.7)
Indications for CEA:
Hemispheric TIA 31 (32.3)
Amaurosis fugax 11 (11.5)
Hemispheric stroke 4 (4.2)
Nonhemispheric TIA 15 (15.6)
Asymptomatic 35 (36.5)
Five-year follow-up results
Survival (%  SE) 81.2  4.6
Freedom from stroke (%  SE) 95.2  2.7
Freedom from ipsilateral
stroke/TIA
93.3  3.0
Freedom from 75% stenosis/
occlusion
98.6  1.3
CEA, carotid endarterectomy; SD, standard deviation; TIA,
transient ischaemic attack; SE, standard error.
772 Y. Louagie et al.the internal jugular veins that are not used for the second
round of bilateral procedures. Finally, synthetic material
has a risk of infection and additional expense.
The disadvantage of the CV patches is their anatomical
variability, particularly on the left side. In their prospective
randomised study, Grego et al9 excluded 9.1% of their
patients because of lack of an adequate external jugular
vein segment noted on a preoperative duplex ultrasound
scan. However, they did not mention the side of the
rejected vessels. In our baseline series of unmatched data,
60.8% of external jugular veins were harvested from the
right side versus 39.2% from the left. Anatomically, the
right external jugular vein is typically larger in diameter
than the left, partly because it is more closely aligned with
the superior vena cava and thus with the right atrium.16 In
addition, numerous anatomical variations have been
described concerning facial vein drainage into the external
jugular vein17 and the termination of the external jugular
vein;18 these variations are asymmetrical and involve more
often the left side. Abeysekara et al12 used suitable
common facial veins in 16 procedures, of which 10 were
right carotid endarterectomies. On two occasions, the vein
was too small and was not used. Both these patients had
a left CEA. These anatomical constraints were a major
stimulus for us to conduct a case-matched study. Indeed,
large studies have suggested a left-hemispheric predilec-
tion of cerebrovascular diseases.19,20 This can be related to
greater haemodynamic stress and intimal damage in the
left carotid artery19 or simply to difficulties in recognising
symptoms caused by a right hemispheric TIA.20 In addition,in cardiac procedures using cardiopulmonary bypass, 75% of
the major perioperative strokes are located in the left
hemisphere.21 Thus, the combination of a left-hemispheric
predilection of neurologic symptoms and the increased
right incidence of external jugular vein patches would have
biased the results.
The hospital mortality of 3.9% in our group undergoing
concomitant cardiac surgery should be compared with the
results of series of simultaneous coronary revascularisation
and CEA.22,23 The 0.8% hospital mortality in our isolated
CEA group compared well with the 0.9% figure of the patch
closure group in the meta-analysis by Bond et al including
seven prospective randomised trials of patch closure versus
primary closure.1
Among the complications involving haemorrhage, there
was no case of patch rupture. In addition, there was no
patch aneurysm during the survey period. This corroborates
the experimental work of Dardik et al. who demonstrated
that the double layer cervical vein segments were similar to
saphenous veins with regard to bursting strength measure-
ments.13 The possibility to choose the best venous substi-
tute and thus avoid small diameter ankle saphenous veins
that have a higher risk of rupture15,24 probably explains the
absence of any haemorrhage that could be related to the
patch itself.
Regarding the early ipsilateral neurologic complications
and internal carotid artery thromboses, we found no
difference among the patch groups. Although patients
undergoing concomitant cardiac surgery were included in
our study, the 1.6% incidence of ipsilateral stroke compared
well with the 1.6% rate of the patch closure group in the
meta-analysis by Bond et al.1
The 8.3% incidence of vocal cord paralysis exceeded the
range of 4e7.7% reported in recent prospective studies.25,26
However, vocal cord palsy can be a complication of cardiac
surgery, particularly with the increased harvesting of
internal thoracic arteries and the use of ice slush as
a myocardial protectant.27 In addition, the inclusion of
repeat carotid procedures increases the risk of that
complication. Finally, all our patients had a systematic
thorough otolaryngologic examination postoperatively with
direct fibroscopy of the vocal cords. This eliminated the risk
of under-reporting asymptomatic vocal cord palsy.
Studies including long-term outcome after everted CV
patch angioplasty are rare (Table 6), particularly those
involving common facial vein patches.8,12 Only three
studies, including the present one, warrant enough follow-
up to afford a 5-year survey of stroke freedom and stenosis/
occlusion freedom. The study by Grego et al.9 showed
outstanding results regarding the 5-year freedom from
stroke. However, because that study was prospective and
randomised, there was a possibility of excluding urgent
cases and we demonstrated by multivariate analysis that
postoperative stroke was associated with urgent proce-
dures. Finally, considering the stenosis/occlusion 5-year
freedom rates, the present study compares well with that
of Grego et al.9
The present report is the only one that included patients
undergoing cardiology procedures and this could influence
both early and long-term complications. The influence of
associated left main stem disease on cervical haemorrhage
and infection can be explained by the necessity to operate
Table 6 Literature review of carotid endarterectomy with everted cervical vein patch angioplasty.
Author/year of
publication
Study design Patch material
(n)
Mean age
(years)
Mean
follow-up
(months)
Stroke
(5-year
freedom)
Stenosis/occlusion
(5-year freedom)
Whereatt et al.10 1990 Retrospective EJV 38, CFV 9 68 29 e e
Dardik et al.8 1997 Prospective Comparative EJV 105, CFV 62 68 26 95.8 82.2
Sabharwal and
Mukherjee.11 1998
Retrospective EJV/CFV 19 63 18 e e
Grego et al.9 2003 Prospective randomized EJV 80 71 48 98.7 90.2
Abeysekara et al.12 2008 Retrospective CFV 16 66 24 e e
Present study Matched comparative EJV 64, CFV 26 67 73 93.2 89.9
EJV, external jugular vein; CFV, common facial vein.
Outcome of Cervical Vein Carotid Patch Angioplasty 773on these patients urgently, while antiaggregants are still
active.
In conclusion, cervical vein carotid patching is proved to
be a safe and reliable technique in our hands, both in the
short and long-term, provided it is applied rigorously.
Cervical veins are a good alternative to SV patching,
particularly when the SV needs to be preserved for further
use or is unsuitable.
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